Results 21 to 30 of about 17,302 (216)
Pevonedistat, an investigational, first-in-class NEDD8-activating enzyme inhibitor, disrupts protein homeostasis, leading to cancer cell death. For patients with higher-risk MDS ineligible for transplant, real-world data reveal median overall survival ...
Zeidner, Joshua +35 more
core +1 more source
During progression of myeloid neoplasms, the basophil compartment may expand substantially and in some of these patients, a basophilic leukemia is diagnosed.
Daniela Berger +16 more
doaj +1 more source
Therapy for acute leukemia in Jehovah’s Witnesses patients is very challenging because of their refusal to accept blood transfusions, a fundamental supportive therapy for this disease.
Yumi Yamamoto +3 more
doaj +1 more source
Thrombocytopenia between azacitidine monotherapy vs low-dose cytarabine monotherapy.
Thrombocytopenia between azacitidine monotherapy vs low-dose cytarabine monotherapy.
Romina Brignardello-Petersen (814592) +7 more
core +1 more source
Anemia events between azacitidine monotherapy vs low-dose cytarabine monotherapy.
Anemia events between azacitidine monotherapy vs low-dose cytarabine monotherapy.
Romina Brignardello-Petersen (814592) +7 more
core +1 more source
Neutropenia events between azacitidine monotherapy vs low-dose cytarabine monotherapy.
Neutropenia events between azacitidine monotherapy vs low-dose cytarabine monotherapy.
Romina Brignardello-Petersen (814592) +7 more
core +1 more source
Background Compared with World Health Organization-defined acute myeloid leukaemia (AML) not otherwise specified, patients with AML with myelodysplasia-related changes (AML-MRC) are generally older and more likely to have poor-risk cytogenetics, leading ...
John F. Seymour +20 more
doaj +1 more source
Overall survival between azacitidine monotherapy vs low-dose cytarabine monotherapy.
Overall survival between azacitidine monotherapy vs low-dose cytarabine monotherapy.
Romina Brignardello-Petersen (814592) +7 more
core +1 more source
Stability studies performed by the pharmaceutical industry are principally designed to fulfill licensing requirements. Thus, post-dilution or post-reconstitution stability data are frequently limited to 24 h only for bacteriological reasons, regardless ...
Antonella Iudicello +4 more
doaj +1 more source
The azacitidine biosynthetic gene cluster (aza BGC) was identified by the resistance‐gene‐guided comparative genomics method in Streptomyces mobaraensis IPIO2. The complete biosynthetic pathway of azacitidine, which follows a “base‐first‐then‐glycosylation” logic, was elucidated through in vivo and in vitro experiments.
Dan Wang +6 more
wiley +2 more sources

